Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q1 2025 Earnings Call Transcript May 9, 2025 Rapid Micro Biosystems, Inc. beats ...

Q1 2025 Earnings Call Transcript May 8, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.42 EPS, ...

ContextLogic Inc. (Nasdaq: LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, ...

General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of option and ...

Research and Development (R&D) Expenses: R&D expenses for the three months ended March 31, 2025, were $4.4 million, compared to $15.8 million for the same period in 2024. The decrease was due ...

Welcome to the Amprius Technologies First Quarter 2025 Earnings Conference Call. Joining us for today's presentation are the Company's CEO, Dr. Kang Sun; and CFO, Sandra Wallach. At this time, all ...

Net revenue for the third quarter of fiscal 2025 was $266.6 million. GAAP net loss for the third quarter of fiscal 2025 was $21.8 million, or a loss of $0.56 per basic share. Non-GAAP net income for ...

Richard Lepke; Senior Director, Investor Relations; Vir Biotechnology Inc. Marianne De Backer; Chief Executive Officer, Director; Vir Biotechnology Inc. Mark Eisner; ...

The latest market snapshot at Tuesday morning reveals DLH Holdings shares down by 0.0%, trading at $3.97.